Skip to main content

Table 2 Twenty-seven common FDA approved drugs derived from signaling network analysis and super-GO analysis

From: Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2

Caffeine

Lenalidomide

Naproxen

Sunitinib

Talniflumate

Lovastatin

Dextromethorphan

Phenylbutazone

Resveratrol

Fostamatinib

Lidocaine

Diclofenac

Thalidomide

Nimesulide

Chloroquine

Gefitinib

Chloroquine

Naloxone

Pazopanib

 

Sorafenib

Simvastatin

Dasatinib

Tofacitinib

 

Nabumetone

Imiquimod

Lapatinib

Afatinib

 
Back to article page

BMC Medical Informatics and Decision Making

ISSN: 1472-6947

Contact us